Primary Azurophilic granules
|
NE (serine protease)
|
Degrades collagen-IV and elastin within ECM [15] |
Positive feedback loop for the inflammatory response [27] |
Targets bacteria’s virulent vectors [28] |
Up-regulates expression of TLR 4 expression in monocytes [27] |
Tissue remodeling [4] |
|
Defensins |
Disrupts cytoplasmic membrane of microbes and induces migration of naïve T cells and immature DCs [29] |
Active adaptive immunity to combat infection [D. 29] |
Induces chemotaxis of CD4+ and CD8+ cells (30) |
Links innate and adaptive immunity through the neutrophil (30) |
|
MPO (peroxidase)
|
Production of antimicrobial oxidants [31] |
Facilitates NET release [32] |
Enables translocation of NE to the nucleus [32] |
Reacts with H2O2 which increases toxic potential by inducing the formation of hypochlorous acid (chlorination products, tyrosine radicals and reactive nitrogen intermediates) [15, 30] |
|
Lysozyme |
Cleaves peptidoglycan polymers of bacterial cell walls [30] |
|
|
Bactericidal/permeability increasing protein (BPI) |
Kills gram-negative bacteria at non-molar concentrations by binding to negatively charged residues of LPS which promotes bacterial attachment and allows for phagocytosis [15, 30] |
|
Endotoxin-neutralizing proteins [15] |
|
Proteinase 3 |
Induces activation of epithelial cells, endothelial cells, macrophages, lymphocytes, and platelets [30] |
|
|
Cathepsin G (serine protease)
|
Kills pathogens [15] |
Tissue remodeling [15] |
Degrades ECM proteins [15] |
Induces activation of epithelial cells, endothelial cells, macrophages, lymphocytes, and platelets [30] |
|
Azurocidin |
Induces chemotaxis of CD4+ and CD8+ cells [30] |
|
Antimicrobial activity [15] |
|
Vitronectin |
Promotes neutrophil adhesion and migration through interaction with integrins [33] |
|
Inhibits apoptosis of neutrophils [33] |
Secondary Specific granules
|
Lactoferrin |
Wide range of microbicidal activity against pathogens (15) |
|
N-terminal amphipathic α-helical region [30] |
Iron-binding proteins and impairs bacterial growth (gram − and +) by sequestration of iron [30] |
|
Collagenase (MMP-1 and MMP-8) |
Degrades major structural components of ECM [30] |
MMP-8 has been deemed a tumor-protective protein, possibly to be an anti-tumor agent against MMP-9 [34] |
Responsible for loss of vascular basement membranes during neutrophil extravasation and migration [30] |
|
M-Ficolin |
Interacts with microbial entities and activates the lectin pathway of the complement cascade [4] |
|
|
Neutrophil gelatinase associated lipocalin |
Antibacterial activity through sequestration of ferric-siderophore complexes [30] |
Is produced commonly by neutrophils in normal, inflamed, and neotissue [30] |
Strongest iron chelators known [35] |
Plays a role in iron-depleting strategy affecting bacterial growth [30] |
|
Human cathelicidin antimicrobial protein-18 (hCAP-18) |
Antimicrobial peptide (−/+), induces chemotaxis of neutrophils, T cells and monocytes when isolated from cathelin propiece [30] |
During wound healing, insulin-like growth factor 1 (IGF-1) induces secretion of hCAP-18 in keratinocytes and hCAP-18 is constitutively expressed in monocytes and lymphocytes elsewhere [30] |
|
Flavocytochrome b558
|
Terminal electron carrier of the assembled respiratory burst oxidase [30] |
|
|
Lysozyme |
Binds LPS and reduces cytokine production [30] |
|
Bactericidal activity against non-pathogenic bacteria [30] |
|
Secretory leukocyte protease inhibitor (SLPI) |
Neutralizes elastase and cathepsin G., activates MMPs, inhibits macrophage MMPs and tumorigenesis; absence of SLPI associated with reduced ECM production and poor healing [36] |
|
|
Pentraxin 3 |
Antimicrobial properties [37] |
Stimulated by LPS, neutrophil activation etc. and can continue to be released in response to inflammatory cytokines [37] |
Microbial recognition [4] |
|
NADPH oxidase |
Aids respiratory burst upon neutrophil activation and subsequent ROS production/release [15] |
|
|
Leukolysin (MMP-25) (10% of total leukolysin present in cell) |
Degrades major structural components of ECM [30] |
|
Loss of vascular basement membranes during neutrophil extravasation and migration [30] |
Tertiary Gelatinase granules
|
Gelatinases A and B (MMP- 2 and MMP-9) |
Degrades major structural components of ECM [30] |
Inhibition of gelatinases results in suppressed neutrophil attachment and migration [38] |
Loss of vascular basement membranes during neutrophil extravasation and migration [30] |
Excessive amounts of MMP-9, potent stimulator of angiogenesis, seen in N2 neutrophils plays a role in invasive tumor growth [34] |
Tissue remodeling [4] |
|
Flavocytochrome b558
|
Terminal electron carrier of the assembled respiratory burst oxidase [30] |
|
|
Arginase-1 |
Inhibits T cell proliferation [39] |
Lack of Arginase-1 is associated with reduced healing, inflammation, increased collagen deposition and mast cell migration [40] |
|
Leukolysin (MMP-25) (40% of total leukolysin present in cell) |
Degrades major structural components of ECM [30] |
Allows for neutrophil migration and matrix reprogramming |
Loss of vascular basement membranes during neutrophil extravasation and migration [30] |
Secretory Vesicles |
β2-integrin CD11b/CD18 (Mac-1, CR3) |
Promotes apoptosis of neutrophils [41] |
When mobilized, there is a shedding of L-selectin from neutrophil’s surface which allows for neutrophil firm contact with the vascular endothelium in vivo [30] |
Increased apoptosis of neutrophils can lead to resolution of inflammation [41] |
|
Formylated bacterial peptides (fMLP-receptors) |
G-PCR |
In LPS stimulated neutrophils, fMLP can inhibit TNF-α providing an anti-inflammatory effect on monocytes and macrophages [42] |
Pro-inflammatory agent [42] |